Comparative analysis of immunization schedules using a novel adenovirus-based immunotherapeutic targeting hepatitis B in naïve and tolerant mouse models-Reference-Cited by-同舟云学术

Comparative analysis of immunization schedules using a novel adenovirus-based immunotherapeutic targeting hepatitis B in naïve and tolerant mouse models

Published:2014-05 Issue:26 Volume:32 Page:3256-3263
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Boukhebza Houda,Dubois Clarisse,Koerper Véronique,Evlachev Alexei,Schlesinger Yasmine,Menguy Thierry,Silvestre Nathalie,Riedl Petra,Inchauspé Geneviève,Martin Perrine

Funder

ANRT

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference33 articles.

1. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity;Ott;Vaccine,2012

2. Impact of therapy on the outcome of chronic hepatitis B;Liaw;Liver Int,2013

3. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection;Bertoletti;Gut,2012

4. Therapeutic vaccination to treat chronic infectious diseases: current clinical developments using MVA-based vaccines;Boukhebza;Hum Vaccin Immunother,2012

5. A therapeutic vaccine against MUC1 expressing tumors;Limacher;Oncoimmunology,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of adenoviral vectors in gene therapy and vaccine approaches;Genetics and Molecular Biology;2022

2. Prospects and progress of DNA vaccines for treating hepatitis B;Expert Review of Vaccines;2016-01-28

3. Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypes;Vaccine;2015-08

4. Hepatitis B virus therapy: What’s the future holding for us?;World Journal of Gastroenterology;2015

5. TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice;Gut;2014-11-26